An Angiotensin II Type 1 Receptor Mutant Lacking Epidermal Growth Factor Receptor Transactivation Does Not Induce Angiotensin II–Mediated Cardiac Hypertrophy
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 99 (5) , 528-536
Abstract
We have shown previously that tyrosine 319 in a conserved YIPP motif in the C terminus of angiotensin II (Ang II) type 1 receptors (AT 1 Rs) is essential for transactivation of epidermal growth factor receptor (EGFR) in vitro. We hypothesized that the signaling mechanism mediated through the specific amino acid sequence in the G protein–coupled receptor plays an important role in mediating cardiac hypertrophy in vivo. Transgenic mice with cardiac-specific overexpression of wild-type AT 1 R (Tg-WT) and an AT 1 R with a mutation in the YIPP motif (Tg-Y319F) were studied. Tg-Y319F mice developed no significant cardiac hypertrophy, in contrast to the significant development of hypertrophy in Tg-WT mice. Expression of fetal-type genes, such as atrial natriuretic factor, was also significantly lower in Tg-Y319F than in Tg-WT mice. Infusion of Ang II caused an enhancement of hypertrophy in Tg-WT mice but failed to induce hypertrophy in Tg-Y319F mice. Left ventricular myocardium in Tg-Y319F mice developed significantly less apoptosis and fibrosis than that in Tg-WT mice. EGFR phosphorylation was significantly inhibited in Tg-Y319F mice, confirming that EGFR was not activated in Tg-Y319F mouse hearts. In contrast, activation/phosphorylation of protein kinase C, STAT3, extracellular signal-regulated kinase, and Akt and translocation of Gαq/11 to the cytosolic fraction were maintained in Tg-Y319F hearts. Furthermore, a genetic cross between Tg-WT and transgenic mice with cardiac-specific overexpression of dominant negative EGFR mimicked the phenotype of Tg-Y319F mice. In conclusion, overexpression of AT 1 -Y319F in cardiac myocytes diminished EGFR transactivation and inhibited a pathological form of cardiac hypertrophy. The YIPP motif in the AT 1 R plays an important role in mediating cardiac hypertrophy in vivo.Keywords
This publication has 33 references indexed in Scilit:
- Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor ReceptorsMolecular Pharmacology, 2005
- Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytesJACC, 2004
- The Angiotensin II Type I Receptor-associated Protein, ATRAP, Is a Transmembrane Protein and a Modulator of Angiotensin II SignalingMolecular Biology of the Cell, 2003
- Ligand-selective receptor conformations revisited: the promise and the problemTrends in Pharmacological Sciences, 2003
- A central role of EGF receptor transactivation in angiotensin II -induced cardiac hypertrophyTrends in Pharmacological Sciences, 2003
- Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cellsThe Prostate, 2002
- β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor StimulationJournal of Biological Chemistry, 2002
- AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKsJournal of Biological Chemistry, 2002
- Tyrosine Kinase Activation by the Angiotensin II Receptor in the Absence of Calcium SignalingJournal of Biological Chemistry, 2001
- Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 ReceptorJournal of Biological Chemistry, 1997